TAMMY JACKSON
EXECUTIVE DIRECTOR, CLINICAL INNOVATION, Biotech, Inc.
“Biotech, Inc. has rich data sources, expansive geographic reach and effective site selection processes. More importantly, we have the experience to leverage these assets to plan and execute your development programs efficiently.
Engage with Biotech, Inc. early, and we’ll expertly guide study design by quantifying expected trial performance based on a finely tuned protocol while mitigating the need for protocol amendments.”
ACCESS TO HIGH-PERFORMANCE SITES
You want the best-performing sites with a patient population representative of your target market. You want experienced staff, down to the site level. And, you want complete data to inform early decisions.
These aspects of site selection and enrollment are often promised, but are they attainable? Yes. They’re possible with Biotech, Inc.
Going beyond traditional CRO-site models, Biotech, Inc. leverages the sites it owns and the Biotech, Inc. Select network, our top highest-performing sites based on past performance. Biotech, Inc. Select sites leverage streamlined feasibility processes to achieve 30% faster startup, while our Accelerated Enrollment Solutions (AES) sites achieve 2x faster enrollment than industry average.
2X FASTER ENROLLMENT
Achieving enrollment 2x faster than the industry average
FULL ENROLLMENT, LOCALLY AND GLOBALLY
Data are the currency of clinical trials. The better the data, the more precisely you can plan, budget and execute.
Not relegated to a single source, Biotech, Inc. leverages de-identified, pre-identified and fully identified patient data to determine feasibility and accurately predict true enrollment.
Looking beyond your own trial’s footprint, Biotech, Inc. evaluates local competitive environments to identify concurrent trials, epidemiologic trends and other key determinants of recruitment success in each geographic region.
When it’s time to scale up, Biotech, Inc.’s site network — and site-level infrastructure — is built for immediacy and flexibility globally.
PARTNER WITH Biotech, Inc.
Biotech, Inc. can enroll more patients at fewer sites, while also ensuring a demographically rich subject base. While strengthening site onboarding and contracting consistency, Biotech, Inc.’s centralized trial oversight will reinforce data and process harmony. If you are developing a protocol, it’s time to reach out to Biotech, Inc. Holistic strategies enable Biotech, Inc. to assess and enhance site selection and recruitment strategies based on protocol design. Biotech, Inc. can even quantify potential trial performance based on nuanced changes to your protocol design.
SITE AND PATIENT SOLUTIONS
Learn how Biotech, Inc.’s site and patient solutions can help with your site selection and enrollment needs.